Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Breakthrough business models [[electronic resource] ] : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies
| Breakthrough business models [[electronic resource] ] : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies |
| Autore | Wizemann Theresa M |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2009 |
| Descrizione fisica | 1 online resource (149 p.) |
| Disciplina | 615/.19 |
| Altri autori (Persone) |
WizemannTheresa M
RobinsonSally GiffinRobert B |
| Soggetto topico |
Orphan drugs - Government policy - United States
Pharmaceutical policy - United States Drugs - Design - United States |
| ISBN |
0-309-17816-9
1-282-08355-4 9786612083556 0-309-12089-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction and overview -- Current model for financing drug development : from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary. |
| Record Nr. | UNINA-9910777913803321 |
Wizemann Theresa M
|
||
| Washington, D.C., : National Academies Press, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Breakthrough business models [[electronic resource] ] : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies
| Breakthrough business models [[electronic resource] ] : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2009 |
| Descrizione fisica | 1 online resource (149 p.) |
| Disciplina | 615/.19 |
| Altri autori (Persone) |
WizemannTheresa M
RobinsonSally GiffinRobert B |
| Soggetto topico |
Orphan drugs - Government policy - United States
Pharmaceutical policy - United States Drugs - Design - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-08355-4
9786612083556 0-309-12089-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910454529203321 |
| Washington, D.C., : National Academies Press, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies
| Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2009 |
| Descrizione fisica | 1 online resource (149 p.) |
| Disciplina | 615/.19 |
| Altri autori (Persone) |
WizemannTheresa M
RobinsonSally GiffinRobert B |
| Soggetto topico |
Orphan drugs - Government policy - United States
Pharmaceutical policy - United States Drugs - Design - United States |
| ISBN |
0-309-17816-9
1-282-08355-4 9786612083556 0-309-12089-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction and overview -- Current model for financing drug development : from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary. |
| Record Nr. | UNINA-9910812068203321 |
| Washington, D.C., : National Academies Press, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fairness in Orphan Drug Exclusivity Act : report (to accompany H.R. 4712)
| Fairness in Orphan Drug Exclusivity Act : report (to accompany H.R. 4712) |
| Pubbl/distr/stampa | [Washington, D.C.] : , : [U.S. Government Publishing Office], , [2020] |
| Descrizione fisica | 1 online resource (11 pages) |
| Collana | Report / 116th Congress, 2d session, House of Representatives |
| Soggetto topico |
Drug development - Economic aspects - United States
Buprenorphine - Therapeutic use - United States Orphan drugs - Government policy - United States Drugs - Prices - Government policy - United States Drugs - Law and legislation - United States Orphan drugs - United States Rare diseases - United States |
| Soggetto genere / forma | Legislative materials. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Fairness in Orphan Drug Exclusivity Act |
| Record Nr. | UNINA-9910715017103321 |
| [Washington, D.C.] : , : [U.S. Government Publishing Office], , [2020] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
